Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 569

1.

Emergence of colistin resistance during treatment of recurrent pneumonia caused by carbapenemase producing Klebsiella pneumoniae.

Matheeussen V, Xavier BB, Mermans I, De Weerdt A, Lammens C, Goossens H, Jansens H, Malhotra-Kumar S.

Diagn Microbiol Infect Dis. 2019 Feb 21. pii: S0732-8893(18)30695-3. doi: 10.1016/j.diagmicrobio.2019.02.014. [Epub ahead of print]

PMID:
30890297
2.

Comparison of the Power of Procalcitonin and C-Reactive Protein to Discriminate between Different Aetiologies of Fever in Prolonged Profound Neutropenia: A Single-Centre Prospective Observational Study.

Verlinden A, De Vroey V, Goossens H, Roelant E, Van De Velde AL, Berneman ZN, Schroyens WA, Gadisseur AP.

Mediterr J Hematol Infect Dis. 2019 Mar 1;11(1):e2019023. doi: 10.4084/MJHID.2019.023. eCollection 2019.

3.

Antibiotic Prescribing for Acute Respiratory Tract Infections 12 Months After Communication and CRP Training: A Randomized Trial.

Little P, Stuart B, Francis N, Douglas E, Tonkin-Crine S, Anthierens S, Cals JWL, Melbye H, Santer M, Moore M, Coenen S, Butler CC, Hood K, Kelson M, Godycki-Cwirko M, Mierzecki A, Torres A, Llor C, Davies M, Mullee M, O'Reilly G, van der Velden A, Geraghty AWA, Goossens H, Verheij T, Yardley L; GRACE consortium.

Ann Fam Med. 2019 Mar;17(2):125-132. doi: 10.1370/afm.2356.

4.
5.

Comparison of the Coris Influ A + B K-SeT® and BD Veritor Flu A + B® for rapid detection of influenza viruses in respiratory samples from 3 consecutive flu seasons in Belgium.

Vandamme S, Van Cleempoel S, Michiels M, Goossens H, Jansens H, Matheeussen V.

Diagn Microbiol Infect Dis. 2019 Jan 25. pii: S0732-8893(18)30368-7. doi: 10.1016/j.diagmicrobio.2019.01.005. [Epub ahead of print] No abstract available.

PMID:
30827806
6.

A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications.

Saleem Z, Hassali MA, Versporten A, Godman B, Hashmi FK, Goossens H, Saleem F.

Expert Rev Anti Infect Ther. 2019 Feb 12:1-9. doi: 10.1080/14787210.2019.1581063. [Epub ahead of print]

PMID:
30755077
7.

Potential in vivo transfer of a blaCTX-M14-harbouring plasmid established by combining long- and short-read sequencing.

Xavier BB, Renzi G, Lammens C, Cherkaoui A, Goossens H, Schrenzel J, Harbarth S, Malhotra-Kumar S.

J Microbiol Methods. 2019 Feb 7;159:1-4. doi: 10.1016/j.mimet.2019.02.004. [Epub ahead of print]

PMID:
30738818
8.

Point Prevalence Survey of Antimicrobial Prescription in a Tertiary Hospital in South East Nigeria: A call for improved antibiotic stewardship.

Umeokonkwo CD, Madubueze UC, Onah CK, Okedo-Alex IN, Adeke AS, Versporten A, Goossens H, Igwe-Okomiso D, Okeke K, Azuogu BN, Onoh R.

J Glob Antimicrob Resist. 2019 Jan 19. pii: S2213-7165(19)30020-7. doi: 10.1016/j.jgar.2019.01.013. [Epub ahead of print]

PMID:
30668994
9.

Comparison of GeneXpert MRSA/SA ETA assay with semi-quantitative and quantitative cultures and nuc gene-based qPCR for detection of Staphylococcus aureus in endotracheal aspirate samples.

Coppens J, Van Heirstraeten L, Ruzin A, Yu L, Timbermont L, Lammens C, Matheeussen V, McCarthy M, Jorens P, Ieven M, Kumar-Singh S, Goossens H, Malhotra-Kumar S.

Antimicrob Resist Infect Control. 2019 Jan 5;8:4. doi: 10.1186/s13756-018-0460-8. eCollection 2019.

10.

The economics of antibiotic resistance: a claim for personalised treatments.

Antoñanzas F, Goossens H.

Eur J Health Econ. 2018 Dec 17. doi: 10.1007/s10198-018-1021-z. [Epub ahead of print] No abstract available.

PMID:
30560434
11.

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing.

Campillo-Davo D, Fujiki F, Van den Bergh JMJ, De Reu H, Smits ELJM, Goossens H, Sugiyama H, Lion E, Berneman ZN, Van Tendeloo V.

Front Immunol. 2018 Nov 7;9:2503. doi: 10.3389/fimmu.2018.02503. eCollection 2018.

12.

ABSTRACTPerformance of the new Illumigene® Mycoplasma LAMP assay for detection of M. pneumonia.

Musger L, Matheeussen V, Loens K, Goossens H.

Acta Clin Belg. 2018 Nov;73(sup1):1-9. doi: 10.1080/17843286.2018.1538724. No abstract available.

PMID:
30430927
13.

Reply to Charra et al.: Global longitudinal assessment of 2019 changes in defined daily doses.

Klein EY, Tseng KK, Levin SA, Goossens H, Laxminarayan R.

Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):E11433-E11435. doi: 10.1073/pnas.1817182115. Epub 2018 Nov 13. No abstract available.

PMID:
30425175
14.

Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan.

Elhajji FD, Al-Taani GM, Anani L, Al-Masri S, Abdalaziz H, Qabba'h SH, Al Bawab AQ, Scott M, Farren D, Gilmore F, Versporten A, Goossens H, Aldeyab MA.

BMC Health Serv Res. 2018 Nov 12;18(1):849. doi: 10.1186/s12913-018-3656-y.

15.

Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network: a COMBACTE LAB-Net survey.

Kostyanev T, Vilken T, Lammens C, Timbermont L, Van't Veen A, Goossens H.

Int J Antimicrob Agents. 2019 Mar;53(3):268-274. doi: 10.1016/j.ijantimicag.2018.10.013. Epub 2018 Oct 31.

16.

Enzymes Catalyzing the TCA- and Urea Cycle Influence the Matrix Composition of Biofilms Formed by Methicillin-Resistant Staphylococcus aureus USA300.

De Backer S, Sabirova J, De Pauw I, De Greve H, Hernalsteens JP, Goossens H, Malhotra-Kumar S.

Microorganisms. 2018 Oct 29;6(4). pii: E113. doi: 10.3390/microorganisms6040113.

17.

Novel composite SCCmec type III element in ST239 MRSA isolated from an Indian hospital.

Coppens J, Xavier BB, Vanjari L, De Backer S, Lammens C, Vemu L, Goossens H, Malhotra-Kumar S.

J Antimicrob Chemother. 2019 Jan 1;74(1):264-266. doi: 10.1093/jac/dky399. No abstract available.

PMID:
30285123
18.

Cost-effectiveness of internet-based training for primary care clinicians on antibiotic prescribing for acute respiratory tract infections in Europe.

Oppong R, Smith RD, Little P, Verheij T, Butler CC, Goossens H, Coenen S, Jowett S, Roberts TE, Achana F, Stuart B, Coast J.

J Antimicrob Chemother. 2018 Nov 1;73(11):3189-3198. doi: 10.1093/jac/dky309.

PMID:
30165522
19.

Remarkable geographical variations between India and Europe in carriage of the staphylococcal surface protein-encoding sasX/sesI and in the population structure of methicillin-resistant Staphylococcus aureus belonging to clonal complex 8.

De Backer S, Xavier BB, Vanjari L, Coppens J, Lammens C, Vemu L, Carevic B, Hryniewicz W, Jorens P, Kumar-Singh S, Lee A, Harbarth S, Schrenzel J, Tacconelli E, Goossens H, Malhotra-Kumar S.

Clin Microbiol Infect. 2018 Aug 2. pii: S1198-743X(18)30542-1. doi: 10.1016/j.cmi.2018.07.024. [Epub ahead of print]

PMID:
30076977
20.

Matching diagnostics development to clinical need: Target product profile development for a point of care test for community-acquired lower respiratory tract infection.

Gal M, Francis NA, Hood K, Villacian J, Goossens H, Watkins A, Butler CC; RAPP-ID consortium.

PLoS One. 2018 Aug 1;13(8):e0200531. doi: 10.1371/journal.pone.0200531. eCollection 2018.

21.

Clinical relevance of bacterial resistance in lower respiratory tract infection in primary care: secondary analysis of a multicentre European trial.

Teepe J, Broekhuizen BD, Goossens H, Hordijk PM, Loens K, Lammens C, Ieven M, Little P, Butler CC, Coenen S, Godycki-Cwirko M, Henriques-Normark B, Verheij TJ; GRACE consortium.

Br J Gen Pract. 2018 Sep;68(674):e627-e632. doi: 10.3399/bjgp18X698333. Epub 2018 Jul 30.

PMID:
30061194
22.

Author Correction: Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox.

Ogunjimi B, Van den Bergh J, Meysman P, Heynderickx S, Bergs K, Jansens H, Leuridan E, Vorsters A, Goossens H, Laukens K, Cools N, Van Tendeloo V, Hens N, Van Damme P, Smits E, Beutels P.

Sci Rep. 2018 Jul 12;8(1):10824. doi: 10.1038/s41598-018-28930-9.

23.

Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol.

Bongard E, van der Velden AW, Cook J, Saville B, Beutels P, Munck Aabenhus R, Brugman C, Chlabicz S, Coenen S, Colliers A, Davies M, De Paor M, De Sutter A, Francis NA, Glinz D, Godycki-Ćwirko M, Goossens H, Holmes J, Ieven M, de Jong M, Lindbaek M, Little P, Martinón-Torres F, Moragas A, Pauer J, Pfeiferová M, Radzeviciene-Jurgute R, Sundvall PD, Torres A, Touboul P, Varthalis D, Verheij T, Butler CC.

BMJ Open. 2018 Jul 12;8(7):e021032. doi: 10.1136/bmjopen-2017-021032.

24.

Using risk adjustment to improve the interpretation of global inpatient pediatric antibiotic prescribing.

Bielicki JA, Sharland M, Versporten A, Goossens H, Cromwell DA.

PLoS One. 2018 Jul 6;13(7):e0199878. doi: 10.1371/journal.pone.0199878. eCollection 2018.

25.

Metrics to assess the quantity of antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure.

Versporten A, Gyssens IC, Pulcini C, Monnier AA, Schouten J, Milanic R, Stanic Benic M, Tebano G, Le Maréchal M, Zanichelli V, Huttner B, Vlahovic-Palcevski V, Goossens H, Hulscher ME, Adriaenssens N; DRIVE-AB WP1 group .

J Antimicrob Chemother. 2018 Jun 1;73(suppl_6):vi59-vi66. doi: 10.1093/jac/dky119.

26.

A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?

Butler CC, Coenen S, Saville BR, Cook J, van der Velden A, Homes J, de Jong M, Little P, Goossens H, Beutels P, Ieven M, Francis N, Moons P, Bongard E, Verheij T.

ERJ Open Res. 2018 May 8;4(2). pii: 00046-2018. doi: 10.1183/23120541.00046-2018. eCollection 2018 Apr.

27.

Analytical performance of a platform for point-of-care CRP testing in adults consulting for lower respiratory tract infection in primary care.

Matheeussen V, Van Hoof V, Loens K, Lammens C, Vanderstraeten A, Coenen S, Butler CC, Little P, Verheij TJM, Goossens H, Ieven M; GRACE consortium.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1319-1323. doi: 10.1007/s10096-018-3253-3. Epub 2018 May 10.

PMID:
29744764
28.

Longitudinal point prevalence survey of antibacterial use in Northern Ireland using the European Surveillance of Antimicrobial Consumption (ESAC) PPS and Global-PPS tool.

Al-Taani GM, Scott M, Farren D, Gilmore F, Mccullagh B, Hibberd C, Mccorry A, Versporten A, Goossens H, Zarb P, Aldeyab MA.

Epidemiol Infect. 2018 Jun;146(8):985-990. doi: 10.1017/S095026881800095X. Epub 2018 Apr 25.

PMID:
29690946
29.

Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.

Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, Jarlier V, Nathwani D, Goossens H; Global-PPS network.

Lancet Glob Health. 2018 Jun;6(6):e619-e629. doi: 10.1016/S2214-109X(18)30186-4. Epub 2018 Apr 23. Erratum in: Lancet Glob Health. 2018 Sep;6(9):e968.

30.

Development of a prediction tool for patients presenting with acute cough in primary care: a prognostic study spanning six European countries.

Bruyndonckx R, Hens N, Verheij TJ, Aerts M, Ieven M, Butler CC, Little P, Goossens H, Coenen S; GRACE project group.

Br J Gen Pract. 2018 May;68(670):e342-e350. doi: 10.3399/bjgp18X695789. Epub 2018 Apr 9.

PMID:
29632005
31.

Global increase and geographic convergence in antibiotic consumption between 2000 and 2015.

Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R.

Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470. doi: 10.1073/pnas.1717295115. Epub 2018 Mar 26.

32.

High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey.

Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H; ARPEC Project Group .

J Pediatric Infect Dis Soc. 2018 Mar 22. doi: 10.1093/jpids/piy019. [Epub ahead of print]

PMID:
29579259
33.

Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries.

Ieven M, Coenen S, Loens K, Lammens C, Coenjaerts F, Vanderstraeten A, Henriques-Normark B, Crook D, Huygen K, Butler CC, Verheij TJM, Little P, Zlateva K, van Loon A, Claas ECJ, Goossens H; GRACE consortium.

Clin Microbiol Infect. 2018 Nov;24(11):1158-1163. doi: 10.1016/j.cmi.2018.02.004. Epub 2018 Feb 12.

PMID:
29447989
34.

Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium.

Willem L, Blommaert A, Hanquet G, Thiry N, Bilcke J, Theeten H, Verhaegen J, Goossens H, Beutels P.

Hum Vaccin Immunother. 2018 May 4;14(5):1218-1229. doi: 10.1080/21645515.2018.1428507. Epub 2018 Feb 22.

35.

Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study.

Stewardson AJ, Vervoort J, Adriaenssens N, Coenen S, Godycki-Cwirko M, Kowalczyk A, Huttner BD, Lammens C, Malhotra-Kumar S, Goossens H, Harbarth S; SATURN WP1 Study Group; SATURN WP3 Study Group.

Clin Microbiol Infect. 2018 Sep;24(9):972-979. doi: 10.1016/j.cmi.2017.12.026. Epub 2018 Jan 10.

PMID:
29331548
36.

Formation of Fluorinated Amido Esters through Unexpected C3-C4 Bond Fission in 4-Trifluoromethyl-3-oxo-β-lactams.

Dao Thi H, Goossens H, Hertsen D, Otte V, Van Nguyen T, Van Speybroeck V, D'hooghe M.

Chem Asian J. 2018 Feb 16;13(4):421-431. doi: 10.1002/asia.201701636. Epub 2018 Jan 29.

PMID:
29316332
37.

Adverse Effects of Amoxicillin for Acute Lower Respiratory Tract Infection in Primary Care: Secondary and Subgroup Analysis of a Randomised Clinical Trial.

Tandan M, Vellinga A, Bruyndonckx R, Little P, Verheij T, Butler CC, Goossens H, Coenen S.

Antibiotics (Basel). 2017 Dec 13;6(4). pii: E36. doi: 10.3390/antibiotics6040036.

38.

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Meysman P, De Neuter N, Bartholomeus E, Elias G, Van den Bergh J, Emonds MP, Haasnoot GW, Heynderickx S, Wens J, Michels NR, Lambert J, Lion E, Claas FHJ, Goossens H, Smits E, Van Damme P, Van Tendeloo V, Beutels P, Suls A, Mortier G, Laukens K, Ogunjimi B.

Immunogenetics. 2018 Jun;70(6):363-372. doi: 10.1007/s00251-017-1047-x. Epub 2017 Dec 1.

PMID:
29196796
39.

Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.

Wouters I, Van Heirstraeten L, Desmet S, Blaizot S, Verhaegen J, Goossens H, Van Damme P, Malhotra-Kumar S, Theeten H; NPcarriage Study Group.

Vaccine. 2018 Jan 2;36(1):15-22. doi: 10.1016/j.vaccine.2017.11.052. Epub 2017 Nov 24.

40.

Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin.

Turlej-Rogacka A, Xavier BB, Janssens L, Lammens C, Zarkotou O, Pournaras S, Goossens H, Malhotra-Kumar S.

Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):345-353. doi: 10.1007/s10096-017-3140-3. Epub 2017 Nov 25.

41.

Mechanical Ventilation Induces Interleukin 4 Secretion in Lungs and Reduces the Phagocytic Capacity of Lung Macrophages.

Bielen K, 's Jongers B, Boddaert J, Lammens C, Jorens PG, Malhotra-Kumar S, Goossens H, Kumar-Singh S.

J Infect Dis. 2018 Apr 23;217(10):1645-1655. doi: 10.1093/infdis/jix573.

PMID:
29140452
42.

Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis by bacterial and viral aetiology.

Bruyndonckx R, Stuart B, Little P, Hens N, Ieven M, Butler CC, Verheij T, Goossens H, Coenen S; GRACE project group.

Clin Microbiol Infect. 2018 Aug;24(8):871-876. doi: 10.1016/j.cmi.2017.10.032. Epub 2017 Nov 3.

PMID:
29108950
44.

Reactivity of 3-Oxo-β-lactams with Respect to Primary Amines-An Experimental and Computational Approach.

Piens N, Goossens H, Hertsen D, Deketelaere S, Crul L, Demeurisse L, De Moor J, Van den Broeck E, Mollet K, Van Hecke K, Van Speybroeck V, D'hooghe M.

Chemistry. 2017 Dec 19;23(71):18002-18009. doi: 10.1002/chem.201703852. Epub 2017 Dec 4.

PMID:
29024090
45.

Rationale and design of ASPIRE-ICU: a prospective cohort study on the incidence and predictors of Staphylococcus aureus and Pseudomonas aeruginosa pneumonia in the ICU.

Paling FP, Troeman DPR, Wolkewitz M, Kalyani R, Prins DR, Weber S, Lammens C, Timbermont L, Goossens H, Malhotra-Kumar S, Sifakis F, Bonten MJM, Kluytmans JAJW.

BMC Infect Dis. 2017 Sep 25;17(1):643. doi: 10.1186/s12879-017-2739-4.

46.
47.

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.

Anguille S, Van de Velde AL, Smits EL, Van Tendeloo VF, Juliusson G, Cools N, Nijs G, Stein B, Lion E, Van Driessche A, Vandenbosch I, Verlinden A, Gadisseur AP, Schroyens WA, Muylle L, Vermeulen K, Maes MB, Deiteren K, Malfait R, Gostick E, Lammens M, Couttenye MM, Jorens P, Goossens H, Price DA, Ladell K, Oka Y, Fujiki F, Oji Y, Sugiyama H, Berneman ZN.

Blood. 2017 Oct 12;130(15):1713-1721. doi: 10.1182/blood-2017-04-780155. Epub 2017 Aug 22.

48.

Human resources estimates and funding for antibiotic stewardship teams are urgently needed.

Pulcini C, Morel CM, Tacconelli E, Beovic B, de With K, Goossens H, Harbarth S, Holmes A, Howard P, Morris AM, Nathwani D, Sharland M, Schouten J, Thursky K, Laxminarayan R, Mendelson M.

Clin Microbiol Infect. 2017 Nov;23(11):785-787. doi: 10.1016/j.cmi.2017.07.013. Epub 2017 Aug 2. No abstract available.

49.

Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of Pseudomonas aeruginosa.

Bielen K, 's Jongers B, Boddaert J, Raju TK, Lammens C, Malhotra-Kumar S, Jorens PG, Goossens H, Kumar-Singh S.

Front Cell Infect Microbiol. 2017 Jun 21;7:274. doi: 10.3389/fcimb.2017.00274. eCollection 2017.

50.

Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration.

Yusuf E, Van Herendael B, Verbrugghe W, Ieven M, Goovaerts E, Bergs K, Wouters K, Jorens PG, Goossens H.

Ann Intensive Care. 2017 Dec;7(1):72. doi: 10.1186/s13613-017-0296-z. Epub 2017 Jun 29.

Supplemental Content

Loading ...
Support Center